Several players operate in the global cancer biomarkers market, catering to niche segment. The global biomarkers market offers a favorable environment for competitors as there are several unique customer segments within the industry, exhibiting demand for distinct product type. However, as market players target multiple pathways, in the near future the market could witness increased competition. Abbott Laboratories, Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., and ... Read more

Global Cancer Biomarkers market size will grow from USD 11.53 Billion in 2017 to USD 23.35 Billion by 2023, at an estimated CAGR of 15.2%. The base year considered for the study is 2017, and the market size is projected from 2018 to 2023.

Major factors driving the growth of the market are rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and rising demand for personalized ... Read more